Further, ICAR-IVRI have jointly developed a Lumpy Skin Disease vaccine and as soon as the technology is made available, Hester will acquire the same and manufacture and commercialize the Lumpy Skin disease Vaccine
Cytel has now established entities in Australia, Shanghai, Beijing, and Singapore, and plans to expand into Seoul and Tokyo in the coming years.
The capital expansion program commenced in June 2022 and is expected to complete in 2024
Company will invest approximately ¥16 billion to increase production capacity by approximately 70% to ensure a stable supply
Abbott has recently received the US Food and Drug Administration nod to use its DBS device for treatment-resistant depression
The expansion at CDMO facility in South Haven, will bring a new 4,000-gallon multi-use reactor train consisting of glass lined and stainless-steel materials of construction
EVERSANA and Compai Pharma will provide medical and commercial resources to healthcare partners
Company is investing more than €100 million in the expansion of the Halle site
This new €59 million, 70,000 square foot facility, officially opened today, brings 50 new jobs to the area
It is only the second healthcare provider in the world to attain the Stage 6 DIAM certification.
Subscribe To Our Newsletter & Stay Updated
